Applying biotechnology and bioengineering to pediatric lung disease: emerging paradigms and platforms by Kelley L Colvin, Michael E Yeager

Get full text

What people with Down Syndrome can teach us about cardiopulmonary disease by Kelley L. Colvin, Michael E. Yeager

Get full text

Biomarkers for pediatric pulmonary arterial hypertension – a call to collaborate by Kelley L Colvin, Kelley L Colvin, Kelley L Colvin, Melanie J Dufva, Ryan P Delaney, D Dunbar Ivy, Kurt R Stenmark, Kurt R Stenmark, Michael E Yeager, Michael E Yeager, Michael E Yeager

Get full text

Increased lethality of respiratory infection by Streptococcus pneumoniae in the Dp16 mouse model of Down syndrome by Kelley L. Colvin, Robert J. Elliott, Desiree M. Goodman, Julie Harral, Edward G. Barrett, Michael E. Yeager

Get full text

Helicity and Vorticity of Pulmonary Arterial Flow in Patients With Pulmonary Hypertension: Quantitative Analysis of Flow Formations by Michal Schäfer, Alex J. Barker, Vitaly Kheyfets, Kurt R. Stenmark, James Crapo, Michael E. Yeager, Uyen Truong, J. Kern Buckner, Brett E. Fenster, Kendall S. Hunter

Get full text

Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome by Katherine A. Waugh, Paula Araya, Ahwan Pandey, Kimberly R. Jordan, Keith P. Smith, Ross E. Granrath, Santosh Khanal, Eric T. Butcher, Belinda Enriquez Estrada, Angela L. Rachubinski, Jennifer A. McWilliams, Ross Minter, Tiana Dimasi, Kelley L. Colvin, Dmitry Baturin, Andrew T. Pham, Matthew D. Galbraith, Kyle W. Bartsch, Michael E. Yeager, Christopher C. Porter, Kelly D. Sullivan, Elena W. Hsieh, Joaquin M. Espinosa

Get full text